Key statistics
As of last trade, Microbot Medical Inc (CY9D:DUS) traded at 1.55, 28.58% above the 52 week low of 1.21 set on Mar 11, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.60 |
|---|---|
| High | 1.63 |
| Low | 1.55 |
| Bid | 1.66 |
| Offer | 1.70 |
| Previous close | 1.59 |
| Average volume | 1.65k |
|---|---|
| Shares outstanding | 67.16m |
| Free float | 67.16m |
| P/E (TTM) | -- |
| Market cap | 123.57m USD |
| EPS (TTM) | -0.4513 USD |
Data delayed at least 15 minutes, as of Feb 11 2026 15:31 GMT.
More ▼
Announcements
- Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption
- Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones
- Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System
- Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
- Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting
- Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System
- Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
- Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio
- Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System
- Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
More ▼
